Cite

HARVARD Citation

    Delgado, J. et al. (2021). EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia. Oncologist. pp. 242-249. [Online]. 
  
Back to record